Axial Spondyloarthritis: Delay in Diagnosis

Mohamad Bittar

Differential Diagnosis of Uveitis Through Ophthalmology & Rheumatolo…

West Virginia State Rheumatology Society

G. Levy-Clarke

EULAR® 2024 Insights: Spot on Treatment Failure in PsA: Where Are th…

EULAR® 2024 Insights

V. Chandran

Spondyloarthritis: IL-17, JAK Inhibitors, and MRI changes at the Spi…

RheumNow

E. Ruderman

EULAR 2023 Insights: How to Diagnose Axial Involvement in PsO/PsA? D…

EULAR 2023 Insights

M. Østergaard

Psoriatic Arthritis Topic Panel: EULAR 2024

RheumNow

E. Ruderman, P. Nash, A. Chan, J. Cush

Keeping Your Eye on the Target: Immune Targets in PsA and SpA

Cleveland Clinic Rheumatology

C. Ritchlin

EULAR® 2024 Insights: Drug Survival of First-line TNF and Apremilast…

EULAR® 2024 Insights

A. Ogdie

EULAR® 2024 Insights - Sex-Related Differences in Trial Outcomes in …

EULAR® 2024 Insights

L. Eder

EULAR® 2024 Insights: Guselkumab Provides Durable Improvements in Pa…

EULAR® 2024 Insights

L. Coates

MSK Exam Workshop

Masterclasses in Dermatology

A. Gottlieb, J. Merola

EULAR® 2024 Insights: Associations Between Clinical Characteristics …

EULAR® 2024 Insights

E. R. Soriano

How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

Difficult to Manage AxSpA

RheumNow

D. Poddubnyy

Patient Advocay in Rheumatology - A Patient Story

Keck School of Medicine of USC

C. Ames

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

EULAR® 2024 Insights - Factors Associated with the Evolution of Dege…

EULAR® 2024 Insights

L. Pina Vegas

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush